No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs10915840 |
chr1:225668524-225668525 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs145548277 |
chr1:225668549-225668550 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs112784674 |
chr1:225668566-225668567 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs547342740 |
chr1:225668570-225668571 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs10915841 |
chr1:225668586-225668587 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs533920794 |
chr1:225668616-225668617 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs188287959 |
chr1:225668624-225668625 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs574172431 |
chr1:225668753-225668754 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs137978326 |
chr1:225668770-225668771 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs372882736 |
chr1:225668772-225668773 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs75601149 |
chr1:225668782-225668783 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs578191469 |
chr1:225668894-225668895 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs545705838 |
chr1:225668903-225668904 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs558691023 |
chr1:225668905-225668906 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs567760831 |
chr1:225668958-225668959 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs560599239 |
chr1:225669005-225669006 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs193200274 |
chr1:225669048-225669049 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs184705177 |
chr1:225669051-225669052 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs560693819 |
chr1:225669069-225669070 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs571143497 |
chr1:225669079-225669080 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs145970787 |
chr1:225669113-225669114 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs114537166 |
chr1:225669175-225669176 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs564755766 |
chr1:225669199-225669200 |
Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs368665485 |
chr1:225669218-225669219 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs532148222 |
chr1:225669236-225669237 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs547698462 |
chr1:225669258-225669259 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs549963754 |
chr1:225669265-225669266 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs534240234 |
chr1:225669298-225669299 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs147051584 |
chr1:225669317-225669318 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs535574835 |
chr1:225669354-225669355 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs189874444 |
chr1:225669421-225669422 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs538357107 |
chr1:225669434-225669435 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs569982989 |
chr1:225669438-225669439 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs114844140 |
chr1:225669447-225669448 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs571895679 |
chr1:225669496-225669497 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs538838774 |
chr1:225669508-225669509 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs72753021 |
chr1:225669566-225669567 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs572645235 |
chr1:225669583-225669584 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs574342264 |
chr1:225669589-225669590 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs554155306 |
chr1:225669633-225669634 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs201790715 |
chr1:225669666-225669667 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs191232027 |
chr1:225669732-225669733 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs34066766 |
chr1:225669742-225669743 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs564616631 |
chr1:225669745-225669746 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs565575406 |
chr1:225669788-225669789 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs138514011 |
chr1:225669804-225669805 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs183864901 |
chr1:225669833-225669834 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs374376399 |
chr1:225669870-225669871 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs559647225 |
chr1:225669909-225669910 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs529953568 |
chr1:225669920-225669921 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|